BioVie Inc. (BIVI)
NASDAQ: BIVI · IEX Real-Time Price · USD
0.470
+0.027 (6.19%)
At close: Jul 26, 2024, 4:00 PM
0.465
-0.005 (-1.06%)
After-hours: Jul 26, 2024, 6:41 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $28.75 million as of July 26, 2024. Its market cap has decreased by -83.79% in one year.
Market Cap
28.75M
Enterprise Value
6.25M
1-Year Change
-83.79%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $28.75M, a decrease of -44.72%. That is a compound annual growth rate of -14.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 27.00M | -43.28% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trinity Biotech | 24.11M |
| Cocrystal Pharma | 24.11M |
| Ekso Bionics Holdings | 24.07M |
| CytoMed Therapeutics | 23.66M |
| Akso Health Group | 23.55M |
| NeuroOne Medical Technologies | 23.11M |
| Nephros | 23.09M |
| Minerva Neurosciences | 22.94M |